<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38047678</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>97</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>21</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Identification of four neutralizing antigenic sites on the enterovirus D68 capsid.</ArticleTitle><Pagination><StartPage>e0160023</StartPage><MedlinePgn>e0160023</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e01600-23</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/jvi.01600-23</ELocationID><Abstract><AbstractText>Enterovirus D68 (EV-D68) is an emerging respiratory pathogen associated with acute flaccid myelitis. Currently, no approved vaccines or antiviral drugs are available. Here, we report four functionally independent neutralizing antigenic sites (I to IV) by analyses of neutralizing monoclonal antibody (MAb)-resistant mutants. Site I is located in the VP1 BC loop near the fivefold axis. Site II resides in the VP2 EF loop, and site III is situated in VP1 C-terminus; both sites are located at the south rim of the canyon. Site IV is composed of residue in VP2 βB strand and residues in the VP3 BC loop and resides around the threefold axis. The developed MAbs targeting the antigenic sites can inhibit viral binding to cells. These findings advance the understanding of the recognition of EV-D68 by neutralizing antibodies and viral evolution and immune escape and also have important implications for the development of novel EV-D68 vaccines.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Dai</LastName><ForeName>Wenlong</ForeName><Initials>W</Initials><Identifier Source="ORCID">0009-0004-0748-3591</Identifier><AffiliationInfo><Affiliation>Department of Pharmaceutics, National Vaccine Innovation Platform, School of Pharmacy, Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zeyu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Chao</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-8658-9009</Identifier><AffiliationInfo><Affiliation>Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>21QA1410000</GrantID><Agency>Shanghai Rising-Star Program</Agency><Country /></Grant><Grant><GrantID>ZD2021CY001</GrantID><Agency>Shanghai Municipal Science and Technology Major Project</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="Y">Antibodies, Neutralizing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002213" MajorTopicYN="N">Capsid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="Y">Capsid Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D030016" MajorTopicYN="Y">Enterovirus D, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antigenic site</Keyword><Keyword MajorTopicYN="N">enterovirus D68</Keyword><Keyword MajorTopicYN="N">epitope</Keyword><Keyword MajorTopicYN="N">escape mutant</Keyword><Keyword MajorTopicYN="N">monoclonal antibody</Keyword><Keyword MajorTopicYN="N">neutralization</Keyword></KeywordList><CoiStatement>C.Z. and W.D. are listed as inventors on a patent related to MAbs 2H12 and 8F12.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>4</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>4</Day><Hour>9</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38047678</ArticleId><ArticleId IdType="pmc">PMC10734511</ArticleId><ArticleId IdType="doi">10.1128/jvi.01600-23</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fields BN, Knipe DM, Howley PM.. 2007. Fields virology, 5th ed. Wolters Kluwer Health/Lippincott Williams &amp; Wilkins, Philadelphia.</Citation></Reference><Reference><Citation>Imamura T, Oshitani H. 2015. Global Reemergence of enterovirus D68 as an important pathogen for acute respiratory infections. Rev Med Virol 25:102–114. doi:10.1002/rmv.1844</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1844</ArticleId><ArticleId IdType="pmc">PMC4407910</ArticleId><ArticleId IdType="pubmed">25471236</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm-Hansen CC, Midgley SE, Fischer TK. 2016. Global emergence of enterovirus D68: a systematic review. Lancet Infect Dis 16:e64–e75. doi:10.1016/S1473-3099(15)00543-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(15)00543-5</ArticleId><ArticleId IdType="pubmed">26929196</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SW, Pons-Salort M, Messacar K, Cook C, Meyers L, Farrar J, Grenfell BT. 2021. Epidemiological dynamics of enterovirus D68 in the United States and implications for acute flaccid myelitis. Sci Transl Med 13:eabd2400. doi:10.1126/scitranslmed.abd2400</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abd2400</ArticleId><ArticleId IdType="pubmed">33692131</ArticleId></ArticleIdList></Reference><Reference><Citation>Sejvar JJ, Lopez AS, Cortese MM, Leshem E, Pastula DM, Miller L, Glaser C, Kambhampati A, Shioda K, Aliabadi N, Fischer M, Gregoricus N, Lanciotti R, Nix WA, Sakthivel SK, Schmid DS, Seward JF, Tong S, Oberste MS, Pallansch M, Feikin D. 2016. Acute flaccid Myelitis in the United States, August-December 2014: results of nationwide surveillance. Clin Infect Dis 63:737–745. doi:10.1093/cid/ciw372</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciw372</ArticleId><ArticleId IdType="pmc">PMC5709818</ArticleId><ArticleId IdType="pubmed">27318332</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer TK, Simmonds P, Harvala H. 2022. The importance of enterovirus surveillance in a post-polio world. Lancet Infect Dis 22:e35–e40. doi:10.1016/S1473-3099(20)30852-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30852-5</ArticleId><ArticleId IdType="pubmed">34265258</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassidy H, Poelman R, Knoester M, Van Leer-Buter CC, Niesters HGM. 2018. Enterovirus D68 - the new polio? Front Microbiol 9:2677. doi:10.3389/fmicb.2018.02677</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.02677</ArticleId><ArticleId IdType="pmc">PMC6243117</ArticleId><ArticleId IdType="pubmed">30483226</ArticleId></ArticleIdList></Reference><Reference><Citation>Schieble JH, Fox VL, Lennette EH. 1967. A probable new human picornavirus associated with respiratory diseases. Am J Epidemiol 85:297–310. doi:10.1093/oxfordjournals.aje.a120693</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a120693</ArticleId><ArticleId IdType="pubmed">4960233</ArticleId></ArticleIdList></Reference><Reference><Citation>Midgley CM, Jackson MA, Selvarangan R, Turabelidze G, Obringer E, Johnson D, Louise Giles B, Patel A, Echols F, Steven Oberste M, Allan Nix W, Watson JT, Gerber SI. 2014. Severe respiratory illness associated with enterovirus D68. American Journal of Transplantation 14:2662–2663. doi:10.1111/ajt.13035</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.13035</ArticleId><ArticleId IdType="pmc">PMC4584696</ArticleId><ArticleId IdType="pubmed">25211545</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G, Zhuge J, Huang W, Nolan SM, Gilrane VL, Yin C, Dimitrova N, Fallon JT. 2017. Enterovirus D68 subclade B3 strain circulating and causing an outbreak in the United States in 2016. Sci Rep 7:1242. doi:10.1038/s41598-017-01349-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-01349-4</ArticleId><ArticleId IdType="pmc">PMC5430842</ArticleId><ArticleId IdType="pubmed">28455514</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HY, Diaz A, Moyer K, Mele-Casas M, Ara-Montojo MF, Torrus I, McCoy K, Mejias A, Leber AL. 2019. Molecular and clinical comparison of enterovirus D68 outbreaks among hospitalized children, Ohio, USA, 2014 and 2018. Emerg Infect Dis 25:2055–2063. doi:10.3201/eid2511.190973</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2511.190973</ArticleId><ArticleId IdType="pmc">PMC6810223</ArticleId><ArticleId IdType="pubmed">31454311</ArticleId></ArticleIdList></Reference><Reference><Citation>McKay SL, Lee AD, Lopez AS, Nix WA, Dooling KL, Keaton AA, Spence-Davizon E, Herlihy R, Clark TA, Hopkins SE, Pastula DM, Sejvar J, Oberste MS, Pallansch MA, Patel M, Routh JA. 2018. Increase in acute flaccid myelitis - United States, 2018. MMWR Morb Mortal Wkly Rep 67:1273–1275. doi:10.15585/mmwr.mm6745e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6745e1</ArticleId><ArticleId IdType="pmc">PMC6290805</ArticleId><ArticleId IdType="pubmed">30439867</ArticleId></ArticleIdList></Reference><Reference><Citation>Midgley SE, Benschop K, Dyrdak R, Mirand A, Bailly J-L, Bierbaum S, Buderus S, Böttcher S, Eis-Hübinger A-M, Hönemann M, Jensen VV, Hartling UB, Henquell C, Panning M, Thomsen MK, Hodcroft EB, Meijer A. 2020. Co-circulation of multiple enterovirus D68 subclades, including a novel B3 cluster, across Europe in a season of expected low prevalence, 2019/20. Euro Surveill 25:1900749. doi:10.2807/1560-7917.ES.2020.25.2.1900749</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.2.1900749</ArticleId><ArticleId IdType="pmc">PMC6976881</ArticleId><ArticleId IdType="pubmed">31964463</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoester M, Helfferich J, Poelman R, Van Leer-Buter C, Brouwer OF, Niesters HGM, 2016 EV-D68 AFM Working Group . 2019. Twenty-nine cases of enterovirus-D68-associated acute flaccid Myelitis in Europe 2016: A case series and epidemiologic overview. Pediatr Infect Dis J 38:16–21. doi:10.1097/INF.0000000000002188</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002188</ArticleId><ArticleId IdType="pmc">PMC6296836</ArticleId><ArticleId IdType="pubmed">30234793</ArticleId></ArticleIdList></Reference><Reference><Citation>Du J, Zheng B, Zheng W, Li P, Kang J, Hou J, Markham R, Zhao K, Yu X-F, Jiang S. 2015. Analysis of enterovirus 68 strains from the 2014 North American outbreak reveals a new clade, indicating viral evolution. PLoS ONE 10:e0144208. doi:10.1371/journal.pone.0144208</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0144208</ArticleId><ArticleId IdType="pmc">PMC4667938</ArticleId><ArticleId IdType="pubmed">26630383</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Sheng J, Fokine A, Meng G, Shin WH, Long F, Kuhn RJ, Kihara D, Rossmann MG. 2015. Structure and inhibition of EV-D68, a virus that causes respiratory illness in children. Science 347:71–74. doi:10.1126/science.1261962</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1261962</ArticleId><ArticleId IdType="pmc">PMC4307789</ArticleId><ArticleId IdType="pubmed">25554786</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Sheng J, van Vliet ALW, Buda G, van Kuppeveld FJM, Rossmann MG. 2018. Molecular basis for the acid-initiated uncoating of human enterovirus D68. Proc Natl Acad Sci U S A 115:E12209–E12217. doi:10.1073/pnas.1803347115</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1803347115</ArticleId><ArticleId IdType="pmc">PMC6310856</ArticleId><ArticleId IdType="pubmed">30530701</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Q, Zhu R, Xu L, He M, Yan X, Liu D, Yin Z, Wu Y, Li Y, Yang L, Hou W, Li S, Li Z, Chen Z, Li Z, Yu H, Gu Y, Zhang J, Baker TS, Zhou ZH, Graham BS, Cheng T, Li S, Xia N. 2019. Atomic structures of enterovirus D68 in complex with two monoclonal antibodies define distinct mechanisms of viral neutralization. Nat Microbiol 4:124–133. doi:10.1038/s41564-018-0275-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0275-7</ArticleId><ArticleId IdType="pmc">PMC6727974</ArticleId><ArticleId IdType="pubmed">30397341</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W, Guo H, Chang J, Yu Y, Liu G, Zhang N, Willard SH, Zheng S, Yu XF. 2016. ICAM-5/telencephalin is a functional entry receptor for enterovirus D68. Cell Host Microbe 20:631–641. doi:10.1016/j.chom.2016.09.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2016.09.013</ArticleId><ArticleId IdType="pubmed">27923705</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Yue, Sheng J, Baggen J, Meng G, Xiao C, Thibaut HJ, van Kuppeveld FJM, Rossmann MG. 2015. Sialic acid-dependent cell entry of human enterovirus D68. Nat Commun 6:8865. doi:10.1038/ncomms9865</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms9865</ArticleId><ArticleId IdType="pmc">PMC4660200</ArticleId><ArticleId IdType="pubmed">26563423</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J, Thibaut HJ, Staring J, Jae LT, Liu Y, Guo H, Slager JJ, de Bruin JW, van Vliet ALW, Blomen VA, Overduin P, Sheng J, de Haan CAM, de Vries E, Meijer A, Rossmann MG, Brummelkamp TR, van Kuppeveld FJM. 2016. Enterovirus D68 receptor requirements unveiled by haploid genetics. Proc Natl Acad Sci U S A 113:1399–1404. doi:10.1073/pnas.1524498113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1524498113</ArticleId><ArticleId IdType="pmc">PMC4747778</ArticleId><ArticleId IdType="pubmed">26787879</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J, Liu Y, Lyoo H, van Vliet ALW, Wahedi M, de Bruin JW, Roberts RW, Overduin P, Meijer A, Rossmann MG, Thibaut HJ, van Kuppeveld FJM. 2019. Bypassing pan-enterovirus host factor PLA2G16. Nat Commun 10:3171. doi:10.1038/s41467-019-11256-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11256-z</ArticleId><ArticleId IdType="pmc">PMC6639302</ArticleId><ArticleId IdType="pubmed">31320648</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai W, Zhang C, Zhang X, Xiong P, Liu Q, Gong S, Geng L, Zhou D, Huang Z. 2018. A virus-like particle vaccine confers protection against enterovirus D68 lethal challenge in mice. Vaccine 36:653–659. doi:10.1016/j.vaccine.2017.12.057</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.12.057</ArticleId><ArticleId IdType="pubmed">29295756</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Zhang X, Zhang W, Dai W, Xie J, Ye L, Wang H, Chen H, Liu Q, Gong S, Geng L, Huang Z. 2018. Enterovirus D68 virus-like particles expressed in Pichia pastoris potently induce neutralizing antibody responses and confer protection against lethal viral infection in mice. Emerg Microbes Infect 7:3. doi:10.1038/s41426-017-0005-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41426-017-0005-x</ArticleId><ArticleId IdType="pmc">PMC5837163</ArticleId><ArticleId IdType="pubmed">29323105</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Zhang X, Dai W, Liu Q, Xiong P, Wang S, Geng L, Gong S, Huang Z. 2018. A mouse model of enterovirus D68 infection for assessment of the efficacy of inactivated vaccine. Viruses 10:58. doi:10.3390/v10020058</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10020058</ArticleId><ArticleId IdType="pmc">PMC5850365</ArticleId><ArticleId IdType="pubmed">29385753</ArticleId></ArticleIdList></Reference><Reference><Citation>Raychoudhuri A, Naru AK, Kanubothula SR, Uddala R. 2021. Development of an experimental inactivated vaccine from Vero cell adapted enterovirus D68. Virus Research 304:198528. doi:10.1016/j.virusres.2021.198528</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2021.198528</ArticleId><ArticleId IdType="pubmed">34339771</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Xu C, Dai W, Wang Y, Liu Z, Zhang X, Wang X, Wang H, Gong S, Cong Y, Huang Z. 2021. Functional and structural characterization of a two-MAb cocktail for delayed treatment of enterovirus D68 infections. Nat Commun 12:2904. doi:10.1038/s41467-021-23199-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23199-5</ArticleId><ArticleId IdType="pmc">PMC8131599</ArticleId><ArticleId IdType="pubmed">34006855</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogt MR, Fu J, Kose N, Williamson LE, Bombardi R, Setliff I, Georgiev IS, Klose T, Rossmann MG, Bochkov YA, Gern JE, Kuhn RJ, Crowe JE. 2020. Human antibodies neutralize enterovirus D68 and protect against infection and paralytic disease. Sci Immunol 5:eaba4902. doi:10.1126/sciimmunol.aba4902</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aba4902</ArticleId><ArticleId IdType="pmc">PMC7418079</ArticleId><ArticleId IdType="pubmed">32620559</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateu MG. 1995. Antibody recognition of picornaviruses and escape from neutralization: a structural view. Virus Res 38:1–24. doi:10.1016/0168-1702(95)00048-u</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-1702(95)00048-u</ArticleId><ArticleId IdType="pubmed">8546007</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai W, Xiong P, Zhang X, Liu Z, Chen J, Zhou Y, Ye X, Zhang C. 2019. Recombinant virus-like particle presenting a newly identified coxsackievirus A10 neutralization EPITOPE induces protective immunity in mice. Antiviral Res 164:139–146. doi:10.1016/j.antiviral.2019.02.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2019.02.016</ArticleId><ArticleId IdType="pubmed">30817941</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Zhang C, Zhou Y, Zhang X, Shen C, Ye X, Jiang W, Huang Z, Cong Y. 2018. A 3.0-angstrom resolution cryo-electron microscopy structure and antigenic sites of coxsackievirus A6-like particles. J Virol 92:e01257-17. doi:10.1128/JVI.01257-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01257-17</ArticleId><ArticleId IdType="pmc">PMC5752931</ArticleId><ArticleId IdType="pubmed">29093091</ArticleId></ArticleIdList></Reference><Reference><Citation>Minor PD, Ferguson M, Evans DM, Almond JW, Icenogle JP. 1986. Antigenic structure of polioviruses of serotypes 1, 2 and 3. J Gen Virol 67 ( Pt 7):1283–1291. doi:10.1099/0022-1317-67-7-1283</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-67-7-1283</ArticleId><ArticleId IdType="pubmed">2425046</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherry B, Mosser AG, Colonno RJ, Rueckert RR. 1986. Use of Monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14. J Virol 57:246–257. doi:10.1128/JVI.57.1.246-257.1986</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.57.1.246-257.1986</ArticleId><ArticleId IdType="pmc">PMC252721</ArticleId><ArticleId IdType="pubmed">2416951</ArticleId></ArticleIdList></Reference><Reference><Citation>Amit AG, Mariuzza RA, Phillips SE, Poljak RJ. 1986. Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution. Science 233:747–753. doi:10.1126/science.2426778</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.2426778</ArticleId><ArticleId IdType="pubmed">2426778</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste MS, Maher K, Schnurr D, Flemister MR, Lovchik JC, Peters H, Sessions W, Kirk C, Chatterjee N, Fuller S, Hanauer JM, Pallansch MA. 2004. Enterovirus 68 is associated with respiratory illness and shares biological features with both the enteroviruses and the rhinoviruses. J Gen Virol 85:2577–2584. doi:10.1099/vir.0.79925-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.79925-0</ArticleId><ArticleId IdType="pubmed">15302951</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherry B, Rueckert R. 1985. Evidence for at least two dominant neutralization antigens on human rhinovirus 14. J Virol 53:137–143. doi:10.1128/JVI.53.1.137-143.1985</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.53.1.137-143.1985</ArticleId><ArticleId IdType="pmc">PMC254989</ArticleId><ArticleId IdType="pubmed">2981332</ArticleId></ArticleIdList></Reference><Reference><Citation>Hrebík D, Füzik T, Gondová M, Šmerdová L, Adamopoulos A, Šedo O, Zdráhal Z, Plevka P. 2021. ICAM-1 induced rearrangements of capsid and genome prime rhinovirus 14 for activation and Uncoating. Proc Natl Acad Sci U S A 118:e2024251118. doi:10.1073/pnas.2024251118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024251118</ArticleId><ArticleId IdType="pmc">PMC8126848</ArticleId><ArticleId IdType="pubmed">33947819</ArticleId></ArticleIdList></Reference><Reference><Citation>Minor PD, Evans DM, Ferguson M, Schild GC, Westrop G, Almond JW. 1985. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3. J Gen Virol 66 ( Pt 5):1159–1165. doi:10.1099/0022-1317-66-5-1159</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-66-5-1159</ArticleId><ArticleId IdType="pubmed">2582084</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Liu C, Shi J, Wang Y, Xu C, Ye X, Liu Q, Li X, Qiao W, Yin Y, Cong Y, Huang Z. 2022. Molecular mechanism of antibody neutralization of coxsackievirus A16. Nat Commun 13:7854. doi:10.1038/s41467-022-35575-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-35575-w</ArticleId><ArticleId IdType="pmc">PMC9769477</ArticleId><ArticleId IdType="pubmed">36543790</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C-C, Chou A-H, Lien S-P, Lin H-Y, Liu S-J, Chang J-Y, Guo M-S, Chow Y-H, Yang W-S, Chang KH-W, Sia C, Chong P. 2011. Identification and characterization of a cross-neutralization EPITOPE of enterovirus 71. Vaccine 29:4362–4372. doi:10.1016/j.vaccine.2011.04.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.04.010</ArticleId><ArticleId IdType="pubmed">21501643</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Liu Z, Yan X, Tian Y, Liu K, Zhao Y, Shao J, Hao P, Zhang C. 2023. VP2 residue N142 of coxsackievirus A10 is critical for the interaction with KREMEN1 receptor and neutralizing antibodies and the pathogenicity in mice. PLoS Pathog 19:e1011662. doi:10.1371/journal.ppat.1011662</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011662</ArticleId><ArticleId IdType="pmc">PMC10547193</ArticleId><ArticleId IdType="pubmed">37788227</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Watters K, Hill MG, Fang Q, Liu Y, Kuhn RJ, Klose T, Rossmann MG, Palmenberg AC. 2020. Cryo-EM structure of rhinovirus C15a bound to its cadherin-related protein 3 receptor. Proc Natl Acad Sci U S A 117:6784–6791. doi:10.1073/pnas.1921640117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1921640117</ArticleId><ArticleId IdType="pmc">PMC7104174</ArticleId><ArticleId IdType="pubmed">32152109</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Wang Y, Zhu Y, Liu C, Gu C, Xu S, Wang Y, Zhou Y, Wang Y, Han W, et al. . 2021. Development and structural basis of a two-MAB cocktail for treating SARS-CoV-2 infections. Nat Commun 12:264. doi:10.1038/s41467-020-20465-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20465-w</ArticleId><ArticleId IdType="pmc">PMC7801428</ArticleId><ArticleId IdType="pubmed">33431876</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>